Clinical Trial Update: CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on ramucirumab (LY3009806) being studied in children and young adults with desmoplastic small round cell tumor in Phase 1/Phase 2; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Desmoplastic Small Round Cell Tumor

Drugs mentioned

• Ramucirumab (ramucirumab)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Desmoplastic Small Round Cell Tumor | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-07-20